Peer Reviewed Publications

Below are recent peer reviewed publications discussing OVA1.  Those highlighted are available online:

  1. Ovarian Malignancy Risk Stratification of the Adnexal Mass Using a Multivariate Index Assay, Bristow, Robert et al, Gynecologic Oncology, Vol 128, Issue 2, Feb 2013, p252-259
  2. Management of Complex Pelvic Passes Using a Multivariate Index Assay:A Decision Analysis, Kim KH, Zsebik GN, Straughn JM Jr, Landen CN Jr., Gynecol Oncol. 2012 Sep;126(3):364-8. 
  3. New Biomarkers for Ovarian Cancer, Andrew John Li, MD, Contemporary OB/GYN, April 2012
  4. Risk of Malignancy in Sonographically Confirmed Ovarian Tumors, Rachel Ware Miller, MD and Frederick R. Ueland, MD, Clinical Obstetrics and Gynecology, Vol 55, No 1, 52-64
  5. An In Vitro Diagnostic Multi Variate Index Assay (IVDMIA) for Ovarian Cancer: Harvesting The Power of Multiple Biomarkers, Zhen Zhang, PhD, Reviews in Obstetrics and Gynecology, Vol.5 No.1 2012
  6. Using a Multivariate Index Assay to Assess Malignancy in a Pelvic Mass, Kenneth Kim, MD and Ronald Alvarez, MD, Obstetrics & Gynecology, Vol.119, No2, Part 1, Feb 2012, p365-367
  7. Ovarian Cancer and OVA1: ROUNDS interviews Frederick R. Ueland, J. Craig Strafford, MD, MPH, ACOG District V Newsletter, July 2011
  8. Effectiveness of a Multivariate Index Assay in the Preoperative Assessment of Ovarian Tumors, Fredrick R. Ueland, Obstetrics & Gynecology, June 2011
  9. Performance of the American College of Obstetricians and Gynecologists' Ovarian Tumor Referral Guidelines With a Multivariate Index Assay, Rachel Ware Miller, MD, Obstetrics & Gynecology, June 2011
  10. OVA1 Test More Accurate than CA125 in Identifying Ovarian Cancer, Contemporary OB/GYN, May 2011
  11. The Role of the Obstetrician-Gynecologist in the Early Detection of Epithelial Ovarian Cancer, ACOG/SGO Committee Opinion, March 2011
  12. OVA1: A New Tool For Evaluating Ovarian Masses, J. Craig Strafford, MD, MPH, ACOG District V Newsletter, March 2011
  13. OVA1 Identifies Early Stage Ovarian Cancer with High Sensitivity, Frederick R. Ueland, MD, IGCS Annual Meeting Poster & Presentation Abstract, October 2010
  14. FDA Clears Test For Ovarian Cancer; Test Can Help Identify Malignancies, Guide Surgical Decisions, FDA Press Release, Sept 11, 2009
  15. Society of Gynecologic Oncologists Statement on OVA1, Sept 2009
  16. AACR Annual Meeting, April 2010 Presentation Abstract: OVA1: An In Vitro Diagnostic Multivariate Index Assay for Preoperative Assessment of Ovarian Tumors, Zhen Zhang, PhD: AACR Annual Meeting Presentation Abstract, April 2010
  17. OVA1 Test For Preoperative Assessment of Ovarian Cancer, Jame Abraham, MD, Community Oncology, June 2010
  18. Replacing CA-125 with OVA1 Correctly Identifies Over 70% of Malignancies Missed by ACOG Criteria, Frederick R. Ueland, MD, Community Oncology, June 2010

An In Vitro Diagnostic Multivariate Index Assay (IVDMIA) for Ovarian Cancer: Harvesting the Power of Multiple Biomarkers